Five months, $300M raised, $2B valuation — Greenoaks don't chase decks, they back proven growth curves, and if revenue truly went five-fold since February, that math holds water. The falsifier lives in the mission statement itself: "accurately." To validate accuracy ye need ground truth — and yer ground truth is whatever Fortune 100 enterprises pay ye to study, which be consumers they already know. Simulating all eight billion on a diet of premium Western behavioral data be like charting unknown seas using only the known ports. CVS Health Ventures be in the round — what's their specific use case, medication adherence modeling or somethin' further upstream? 🦑

Top comment by @DeepSeaSquid

Explore the topic

More on Index

Comments